{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:24:49Z","timestamp":1792808689267,"version":"4.5.0"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objective: Childhood cancer survival rates have improved, but survivors face an increased risk of second malignant neoplasms (SMNs), particularly thyroid cancer. This study examines the demographic, clinical, genetic, and treatment characteristics of childhood cancer survivors who developed thyroid cancer as a second or third malignancy, emphasizing the importance of long-term surveillance. Methods: A retrospective review was conducted for childhood cancer survivors treated between 1990 and 2018 who later developed thyroid cancer as a second or third malignancy. Data on demographics, clinical characteristics, treatment, and outcomes were analyzed. Results: Among the 3204 childhood cancer survivors, 10 patients (6 female, 4 male) developed papillary thyroid carcinoma (PTC), a median of 9 years post-initial diagnosis. Radiation therapy, particularly to the head and neck, was commonly used. Genetic testing revealed mutations in the Cell Cycle CheckPoint Kinase 2 (CHEK2) and Adenomatous Polyposis Coli (APC) genes in four patients, possibly contributing to the increased risk. All were diagnosed through thyroid ultrasound and underwent total thyroidectomy, and three received radioactive iodine (RAI). No recurrences or deaths related to PTC occurred, with a median follow-up of 5.5 years after diagnosis. Conclusions: Radiation therapy, especially combined with chemotherapy, significantly increases the risk of thyroid cancer in childhood cancer survivors. Genetic predispositions also play a role. Lifelong thyroid cancer surveillance is essential, particularly for those who received radiation or chemotherapy. Further research is needed to refine surveillance strategies and better understand genetic factors that influence thyroid cancer risk. Early detection and ongoing monitoring are critical for improving long-term outcomes.<\/jats:p>","DOI":"10.3390\/jcm14020589","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T11:24:56Z","timestamp":1737113096000},"page":"589","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thyroid Cancer in Childhood Cancer Survivors: Demographic, Clinical, Germline Genetic Characteristics, Treatment, and Outcome"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0585-5123","authenticated-orcid":false,"given":"Ulku Miray","family":"Yildirim","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejin","family":"Kebudi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u00e7a","family":"\u0130riba\u015f \u00c7elik","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical Faculty, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"Z\u00fclfikar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abut","family":"Kebudi","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Medical Faculty, Okan University, 34947 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S1470-2045(19)30273-6","article-title":"Global childhood cancer survival estimates and priority-setting: A simulation-based analysis","volume":"20","author":"Ward","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1573396313666161114233135","article-title":"Secondary Neoplasms in Children Treated for Cancer","volume":"13","author":"Kebudi","year":"2017","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_3","first-page":"64","article-title":"Risk factors of Second Malignant Neoplasms in Childhood Cancer Survivors","volume":"14","author":"Bahrami","year":"2024","journal-title":"Iran. J. Pediatr. Hematol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10654-018-0467-8","article-title":"Radiotherapy for childhood cancer and subsequent thyroid cancer risk: A systematic review","volume":"33","author":"Lorenz","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Martucci, C., Crocoli, A., De Pasquale, M.D., Spinelli, C., Strambi, S., Brazzarola, P., Morelli, E., Cassiani, J., Mancera, J., and Luengas, J.P. (2022). Thyroid cancer in children: A multicenter international study highlighting clinical features and surgical outcomes of primary and secondary tumors. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.914942"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/thy.2019.0561","article-title":"Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D","volume":"30","author":"Nieminen","year":"2020","journal-title":"Thyroid"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.2011.747","article-title":"Long-term risks of subsequent primary neoplasms among survivors of childhood cancer","volume":"305","author":"Reulen","year":"2011","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2023.16875","article-title":"Clinical Care for People Who Survive Childhood Cancer: A Review","volume":"330","author":"Bhatia","year":"2023","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.14694\/EdBook_AM.2014.34.e57","article-title":"The Rising Incidence of Second Cancers: Patterns of Occurrence and Identification of Risk Factors for Children and Adults","volume":"34","author":"Morton","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/01.sla.0000118752.34052.b7","article-title":"Latency period of thyroid neoplasia after radiation exposure","volume":"239","author":"Kikuchi","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2017.11.005","article-title":"Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium","volume":"63","author":"Clement","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1667\/RR2240.1","article-title":"Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: An update from the childhood cancer survivor study","volume":"174","author":"Bhatti","year":"2010","journal-title":"Radiat. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/1055-9965.EPI-11-0576","article-title":"Chemotherapy and thyroid cancer risk: A report from the childhood cancer survivor study","volume":"21","author":"Veiga","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1667\/RR2889.1","article-title":"A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer","volume":"178","author":"Veiga","year":"2012","journal-title":"Radiat. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1096-911X(199808)31:2<91::AID-MPO8>3.0.CO;2-U","article-title":"Secondary thyroid carcinoma after treatment for childhood cancer","volume":"31","author":"Black","year":"1998","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0140-6736(05)66695-0","article-title":"Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study","volume":"365","author":"Sigurdson","year":"2005","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/mpo.1132","article-title":"Thyroid cancer after radiotherapy for childhood cancer","volume":"36","author":"Inskip","year":"2001","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2307\/3578892","article-title":"Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958\u20131987","volume":"137","author":"Thompson","year":"1994","journal-title":"Radiat. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/ijc.24581","article-title":"Risk of thyroid cancer in survivors of childhood cancer: Results from the British Childhood Cancer Survivor Study","volume":"125","author":"Taylor","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/pbc.24681","article-title":"Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: Importance of continuous surveillance","volume":"60","author":"Clement","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/thy.2011.0464","article-title":"Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: Description of the first two cases","volume":"22","author":"Tytgat","year":"2012","journal-title":"Thyroid"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/sj.onc.1202925","article-title":"Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway","volume":"18","author":"Chaturvedi","year":"1999","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","article-title":"Chk1 and Chk2 kinases in checkpoint control and cancer","volume":"3","author":"Bartek","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1086\/375121","article-title":"The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype","volume":"72","author":"Wijnen","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/PO.20.00218","article-title":"Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma","volume":"5","author":"Kim","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hanson, H., Astiazaran-Symonds, E., Amendola, L.M., Balmana, J., Foulkes, W.D., James, P., Klugman, S., Ngeow, J., Schmutzler, R., and Voian, N. (2023). Electronic address, d. a. n., Management of individuals with germline pathogenic\/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet. Med., 25.","DOI":"10.1016\/j.gim.2023.100870"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Singh, A., Ham, J., Po, J.W., Niles, N., Roberts, T., and Lee, C.S. (2021). The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy. Cells, 10.","DOI":"10.3390\/cells10051082"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Perrino, M., Cooke-Barber, J., Dasgupta, R., and Geller, J.I. (2019). Genetic predisposition to cancer: Surveillance and intervention. Semin. Pediatr. Surg., 28.","DOI":"10.1016\/j.sempedsurg.2019.150858"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Xu, P., Gao, Y., Jiang, S., Cui, Y., Xie, Y., Kang, Z., Chen, Y.X., Sun, D., and Fang, J.Y. (2024). CHEK2 deficiency increase the response to PD-1 inhibitors by affecting the tumor immune microenvironment. Cancer Lett., 588.","DOI":"10.1016\/j.canlet.2023.216595"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/jmp5030019","article-title":"DICER1 Tumor Syndrome: A Retrospective Review and Future Perspectives","volume":"5","author":"Cazzato","year":"2024","journal-title":"J. Mol. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Riascos, M.C., Huynh, A., Faquin, W.C., and Nose, V. (2024). Expanding Our Knowledge of DICER1 Gene Alterations and Their Role in Thyroid Diseases. Cancers, 16.","DOI":"10.3390\/cancers16020347"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1210\/jc.2016-2954","article-title":"Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study","volume":"102","author":"Khan","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","article-title":"DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies","volume":"24","author":"Schultz","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Miasaki, F.Y., Fuziwara, C.S., Carvalho, G.A., and Kimura, E.T. (2020). Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer. Genes, 11.","DOI":"10.3390\/genes11111364"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/589\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:30:56Z","timestamp":1759919456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["jcm14020589"],"URL":"https:\/\/doi.org\/10.3390\/jcm14020589","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}